# Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dabrafenib-plus-trametinib-in-patients-with-brafv600e-mutated-biliary-tract/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Vivek Subbiah,Ulrik Lassen,Elena Élez,Antoîne Italiano,Giuseppe Curigliano,Milind Javle,Filippo de Braud,Gerald W. Prager,Richard Greil,Alexander Stein,Angelica Fasolo,Jan H.M. Schellens,Patrick Y. Wen,Kert Viele,Aislyn Boran,Eduard Gasal,Paul Burgess,Palanichamy Ilankumaran,Zev A. Wainberg |
| Citations | 531 |
| DOI | 10.1016/s1470-2045(20)30321-1 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3049104202 |
| PMID | 32818466 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Gerald W. Prager](https://scholariq.org/researchers/gerald-w-prager/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Paper topics

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.